Bioventix PLC (BVXP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,650.00p

Buy

1,750.00p

arrow-down-25.00p (-1.45%)

Prices updated at 12 Dec 2025, 16:23 GMT

Prices minimum 15 mins delay

Prices in GBX

Bioventix PLC is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Ian James Nicholson

CEO

Mr. Peter John Harrison

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

16

Head office

27-28 Eastcastle Street

London

United Kingdom

W1W 8DH

-

info@bioventix.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Ian James Nicholson Non-Executive Director, Chairman	-
Mr. Bruce Edward Heath Hiscock Executive Director, Chief Financial Officer	-
Mr. Peter John Harrison Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Liontrust Investment Partners LLP	554,938
Liontrust UK Smaller Companies Fund	478,827
WS Gresham House UK Multi Cap Income Fd	421,126
TM SDL UK Buffettology Fund	406,500
Santander Asset Management UK Limited	217,807

Director dealings

Date chevron-l-regular chevron-r-regular	Action
25 Nov 2025	Purchase
04 Nov 2025	Purchase
04 Nov 2025	Purchase
29 Oct 2025	Purchase
27 Oct 2025	Purchase
28 Apr 2025	Purchase
16 Apr 2025	Exercise of Option
23 Dec 2024	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.